Alex Azar

Alex Azar
Name	Alex Azar
Birth date	1967-06-17
Birth place	Indianapolis, Indiana, U.S.
Nationality	American
Occupation	Attorney, Executive, Government Official
Alma mater	Yale University; Harvard Law School
Known for	Former United States Secretary of Health and Human Services

Alex Azar

Alex Michael Azar II is an American attorney, pharmaceutical executive, and former government official who served as the United States Secretary of Health and Human Services from 2018 to 2021. He previously held senior roles in the United States Department of Health and Human Services during the George W. Bush administration and was president of the U.S. division of Eli Lilly and Company. His tenure bridged high-level roles in federal agencies, corporate leadership in the pharmaceutical industry, and public policy engagement on healthcare and drug pricing.

Early life and education

Born in Indianapolis, Indiana, Azar grew up in a family with roots in Lebanon and attended DePauw University-affiliated preparatory schooling before matriculating at Yale University, where he earned a Bachelor of Arts. He subsequently studied law at Harvard Law School, receiving a Juris Doctor, and completed internships and clerkships that connected him with figures from the U.S. Department of Justice, the U.S. House of Representatives, and firms practicing regulatory and healthcare law.

Legal and private-sector career

After law school, Azar joined the United States Department of Justice as an aide and served as a law clerk for a federal judge, then moved into roles advising members of the United States Senate and the United States House of Representatives on legislative and policy matters. He worked at prominent law firms in Washington, D.C. that represented healthcare and life-sciences clients, and later transitioned to in-house counsel roles with ties to regulatory affairs at pharmaceutical companies. His legal background linked him with officials in the Office of Management and Budget, the Food and Drug Administration, and advocacy groups engaged in health policy debates.

Pharmaceutical industry leadership

Azar joined Eli Lilly and Company in senior legal and corporate positions and rose to become president of Lilly's U.S. operations, overseeing commercial strategy, regulatory interactions, and market access. In that capacity he engaged with industry trade associations such as the Pharmaceutical Research and Manufacturers of America and interacted with stakeholders including executives from Pfizer, Merck & Co., Johnson & Johnson, and Novartis. His tenure coincided with debates over prescription drug pricing, interactions with the Centers for Medicare & Medicaid Services, and negotiations with pharmacy benefit managers and insurers including UnitedHealth Group and CVS Health. Prior to Lilly, Azar's corporate roles involved pharmaceutical corporate compliance and litigation management, with connections to transactional and regulatory practice areas linked to the Securities and Exchange Commission and federal health programs.

United States Secretary of Health and Human Services

Nominated by President Donald Trump and confirmed by the United States Senate, Azar assumed leadership of the United States Department of Health and Human Services. His tenure encompassed federal responses to public-health challenges, coordination with agencies such as the Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health, and engagement with congressional committees including the Senate Committee on Finance and the House Committee on Energy and Commerce. He advocated policies on drug pricing, regulatory reform, telemedicine expansion, and value-based payment models that intersected with programs like Medicare and Medicaid. Azar also oversaw HHS activities during the early stages of the COVID-19 pandemic, interfacing with state governors, the World Health Organization, and federal entities involved in vaccine and therapeutic development, including public-private partnerships with manufacturers such as Moderna and AstraZeneca.

Post-government activities and advocacy

After leaving federal office, Azar engaged in public speaking, advisory roles, and commentary on healthcare policy, biotechnology innovation, and pharmaceutical regulation. He has participated in forums hosted by think tanks and institutions such as The Brookings Institution, The Heritage Foundation, and academic centers at Harvard University and Yale University. Azar has been involved in advocacy around regulatory pathways for medical products, intellectual property considerations relevant to the life-sciences sector, and proposals to modify drug-pricing mechanisms debated in the United States Congress and state legislatures. He has consulted with corporations and nonprofit organizations focusing on global health, pandemic preparedness, and market access strategies.

Personal life and affiliations

Azar is married and has a family; his personal affiliations have included membership or engagement with professional associations and boards connected to health law, biotechnology, and leadership development. He has delivered lectures at universities and participated in panel discussions with public officials and industry leaders from institutions such as Johns Hopkins University, Columbia University, Stanford University, and Georgetown University. His background and career link him to communities spanning Indiana, Washington, D.C., and international health networks.

Category:1967 births Category:Living people Category:United States Secretaries of Health and Human Services Category:Eli Lilly and Company people